Table 1

Baseline characteristics of the patients

VariablesEntire cohortPropensity score-matched cohort
EVT
(n=184)
No EVT
(n=188)
P valuesEVT
(n=184)
No EVT
(n=184)
P values
Age, mean (SD)73 (10)74 (11)0.2373 (10)74 (12)0.11
Male, n (%)110 (60)109 (58)0.75110 (60)103 (56)0.52
NIHSS score, median (IQR)15 (9–19)10 (5–16)<0. 000115 (9–19)12 (9–19)0.16
ASPECTS, median (IQR) [min - max]8 (7–9) [3–10]8 (7–9) [0–10]0.598 (7–9) [3–10]7 (7–9) [4–10]0.92
Use of IV tPA, n (%)93 (51)100 (53)0.6793 (51)96 (52)0.83
Process times (min), median (IQR)
Onset to door110 (50–258)150 (60–343)0.01110 (50–258)120 (55–213)0.88
Onset to puncture195 (128–386)NA195 (128–386)NA
Onset to reperfusion265 (180–470)NA265 (180–470)NA
Endovascular therapy
Using stent retrievers (%)102 (55)NA102 (55)NA
  • ASPECTS, Alberta Stroke Programme Early CT Score; EVT, endovascular therapy; IQR, interquartile range; IV tPA, intravenous tissue plasminogen activator; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale.